DEA maintains psilocybin/MDMA as Schedule I; no final administrative rescheduling rule published in 2026.

Predicted 2026-07-20 · Resolves 2026-12-31 · regulatory · USA

74%

ORACLE CONFIDENCE

⏳ Pending

Every outcome is scored publicly in the ledger.

By the end of 2026, the DEA is almost certainly not going to publish a final, binding rule moving psilocybin or MDMA off Schedule I — the most restrictive category of illegal drugs. The process for doing that is slow, complex, and not close to finished. This means federal law continues to treat these substances the same way it treats heroin.

Resolution rule: YES if, as of 2026-12-31, no FINAL rule rescheduling psilocybin or MDMA out of Schedule I has been published in the Federal Register (federalregister.gov, DEA docket). A proposed rule or interim rule does NOT count as YES-negating. NO if a final rescheduling rule is published by that date.

Diversion evidence is mounting, not receding. The bar for administrative rescheduling won't be met this year; any movement is procedural, not final.

5 new falsifiable predictions, every day at 12:05 PM ET.

Get tomorrow's Oracle →